Literature DB >> 21803943

EP₃ receptors mediate PGE₂-induced hypothalamic paraventricular nucleus excitation and sympathetic activation.

Zhi-Hua Zhang1, Yang Yu, Shun-Guang Wei, Yoshiko Nakamura, Kazuhiro Nakamura, Robert B Felder.   

Abstract

Prostaglandin E(2) (PGE(2)), an important mediator of the inflammatory response, acts centrally to elicit sympathetic excitation. PGE(2) acts on at least four E-class prostanoid (EP) receptors known as EP(1), EP(2), EP(3), and EP(4). Since PGE(2) production within the brain is ubiquitous, the different functions of PGE(2) depend on the expression of these prostanoid receptors in specific brain areas. The type(s) and location(s) of the EP receptors that mediate sympathetic responses to central PGE(2) remain unknown. We examined this question using PGE(2), the relatively selective EP receptor agonists misoprostol and sulprostone, and the available selective antagonists for EP(1), EP(3), and EP(4). In urethane-anesthetized rats, intracerebroventricular (ICV) administration of PGE(2), sulprostone or misoprostol increased renal sympathetic nerve activity, blood pressure, and heart rate. These responses were significantly reduced by ICV pretreatment with the EP(3) receptor antagonist; the EP(1) and EP(4) receptor antagonists had little or no effect. ICV PGE(2) or misoprostol increased the discharge of neurons in the hypothalamic paraventricular nucleus (PVN). ICV misoprostol increased the c-Fos immunoreactivity of PVN neurons, an effect that was substantially reduced by the EP(3) receptor antagonist. Real-time PCR detected EP(3) receptor mRNA in PVN, and immunohistochemical studies revealed sparsely distributed EP(3) receptors localized in GABAergic terminals and on a few PVN neurons. Direct bilateral PVN microinjections of PGE(2) or sulprostone elicited sympathoexcitatory responses that were significantly reduced by the EP(3) receptor antagonist. These data suggest that EP(3) receptors mediate the central excitatory effects of PGE(2) on PVN neurons and sympathetic discharge.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21803943      PMCID: PMC3197370          DOI: 10.1152/ajpheart.00262.2011

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  53 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

Review 2.  How the blood talks to the brain parenchyma and the paraventricular nucleus of the hypothalamus during systemic inflammatory and infectious stimuli.

Authors:  S Rivest; S Lacroix; L Vallières; S Nadeau; J Zhang; N Laflamme
Journal:  Proc Soc Exp Biol Med       Date:  2000-01

3.  Prostanoid EP(1)- and TP-receptors involved in the contraction of human pulmonary veins.

Authors:  L Walch; V de Montpreville; C Brink; X Norel
Journal:  Br J Pharmacol       Date:  2001-12       Impact factor: 8.739

4.  Distribution of the EP3 prostaglandin E(2) receptor subtype in the rat brain: relationship to sites of interleukin-1-induced cellular responsiveness.

Authors:  M Ek; C Arias; P Sawchenko; A Ericsson-Dahlstrand
Journal:  J Comp Neurol       Date:  2000-12-04       Impact factor: 3.215

5.  Relationship of EP(1-4) prostaglandin receptors with rat hypothalamic cell groups involved in lipopolysaccharide fever responses.

Authors:  T Oka; K Oka; T E Scammell; C Lee; J F Kelly; F Nantel; J K Elmquist; C B Saper
Journal:  J Comp Neurol       Date:  2000-12-04       Impact factor: 3.215

Review 6.  Neurohumoral regulation in ischemia-induced heart failure. Role of the forebrain.

Authors:  R B Felder; J Francis; R M Weiss; Z H Zhang; S G Wei; A K Johnson
Journal:  Ann N Y Acad Sci       Date:  2001-06       Impact factor: 5.691

7.  Immunohistochemical localization of prostaglandin EP3 receptor in the rat nervous system.

Authors:  K Nakamura; T Kaneko; Y Yamashita; H Hasegawa; H Katoh; M Negishi
Journal:  J Comp Neurol       Date:  2000-06-12       Impact factor: 3.215

Review 8.  How circulating cytokines trigger the neural circuits that control the hypothalamic-pituitary-adrenal axis.

Authors:  S Rivest
Journal:  Psychoneuroendocrinology       Date:  2001-11       Impact factor: 4.905

9.  Reduced endogenous GABA-mediated inhibition in the PVN on renal nerve discharge in rats with heart failure.

Authors:  Kun Zhang; Yi-Fan Li; Kaushik P Patel
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2002-04       Impact factor: 3.619

10.  Forebrain renin-angiotensin system has a tonic excitatory influence on renal sympathetic nerve activity.

Authors:  Shun-Guang Wei; Robert B Felder
Journal:  Am J Physiol Heart Circ Physiol       Date:  2002-03       Impact factor: 4.733

View more
  15 in total

Review 1.  Central nervous system circuits modified in heart failure: pathophysiology and therapeutic implications.

Authors:  Bernardo Sousa-Pinto; Manuel J Ferreira-Pinto; Mário Santos; Adelino F Leite-Moreira
Journal:  Heart Fail Rev       Date:  2014-11       Impact factor: 4.214

2.  Peroxisome proliferator-activated receptor-γ regulates inflammation and renin-angiotensin system activity in the hypothalamic paraventricular nucleus and ameliorates peripheral manifestations of heart failure.

Authors:  Yang Yu; Zhi-Hua Zhang; Shun-Guang Wei; Robert M Weiss; Robert B Felder
Journal:  Hypertension       Date:  2011-11-14       Impact factor: 10.190

Review 3.  Distinct roles of central and peripheral prostaglandin E2 and EP subtypes in blood pressure regulation.

Authors:  Tianxin Yang; Yaomin Du
Journal:  Am J Hypertens       Date:  2012-06-14       Impact factor: 2.689

Review 4.  Roles of EP Receptors in the Regulation of Fluid Balance and Blood Pressure.

Authors:  Lu Wang; Yiqian Wu; Zhanjun Jia; Jing Yu; Songming Huang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-23       Impact factor: 6.055

5.  Rostral Ventrolateral Medulla EP3 Receptor Mediates the Sympathoexcitatory and Pressor Effects of Prostaglandin E2 in Conscious Rats.

Authors:  Samar Rezq; Abdel A Abdel-Rahman
Journal:  J Pharmacol Exp Ther       Date:  2016-08-29       Impact factor: 4.030

6.  Inactivation of the E-prostanoid 3 receptor attenuates the angiotensin II pressor response via decreasing arterial contractility.

Authors:  Lihong Chen; Yifei Miao; Yahua Zhang; Dou Dou; Limei Liu; Xiaoyu Tian; Guangrui Yang; Dan Pu; Xiaoyan Zhang; Jihong Kang; Yuansheng Gao; Shiqiang Wang; Matthew D Breyer; Nanping Wang; Yi Zhu; Yu Huang; Richard M Breyer; Youfei Guan
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-10-11       Impact factor: 8.311

7.  PGE2-EP3 signaling exacerbates hippocampus-dependent cognitive impairment after laparotomy by reducing expression levels of hippocampal synaptic plasticity-related proteins in aged mice.

Authors:  Jing-Yu Xiao; Bing-Rui Xiong; Wen Zhang; Wen-Chang Zhou; Hui Yang; Feng Gao; Hong-Bing Xiang; Anne Manyande; Xue-Bi Tian; Yu-Ke Tian
Journal:  CNS Neurosci Ther       Date:  2018-02-27       Impact factor: 5.243

Review 8.  Autonomic nervous system and immune system interactions.

Authors:  M J Kenney; C K Ganta
Journal:  Compr Physiol       Date:  2014-07       Impact factor: 9.090

9.  Brain perivascular macrophages contribute to the development of hypertension in stroke-prone spontaneously hypertensive rats via sympathetic activation.

Authors:  Takeshi Iyonaga; Keisuke Shinohara; Taku Mastuura; Yoshitaka Hirooka; Hiroyuki Tsutsui
Journal:  Hypertens Res       Date:  2019-09-20       Impact factor: 3.872

10.  Central EP3 (E Prostanoid 3) Receptors Mediate Salt-Sensitive Hypertension and Immune Activation.

Authors:  Liang Xiao; Hana A Itani; Luciana Simao do Carmo; Lucas S Carver; Richard M Breyer; David G Harrison
Journal:  Hypertension       Date:  2019-11-04       Impact factor: 9.897

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.